2022
DOI: 10.1021/acsnano.2c09834
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound-Remote Selected Activation Mitophagy for Precise Treatment of Rheumatoid Arthritis by Two-Dimensional Piezoelectric Nanosheets

Abstract: Excess reactive oxygen species (ROS) produced by abnormal mitochondria is one of the critical triggers of rheumatoid arthritis (RA). Existing nanocatalytic therapies can only catalyze the breakdown of ROS but cannot address the root cause of ROS production, i.e., abnormal mitochondria. Here, we designed an ultrasound (US) piezoelectric catalytic therapy, which can induce mitophagy in a spatiotemporally controlled manner to treat RA. The prepared two-dimensional piezoelectric nanosheets (NSs) Fe/BiOCl with US c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
21
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 25 publications
(22 citation statements)
references
References 23 publications
1
21
0
Order By: Relevance
“…Notably, after 3 days of continuous incubation, Ce predominantly deposited in liver, spleen, and kidney of the mice (Figure S10B). The observations immediately suggested that Ce species released from decomposed micelles could be gradually excreted from the body after completing their anti-inflammatory functions and was also consistent with the excretion mechanisms of transitional metal species in previous reports, thus achieving balanced RA treatment efficacy and long-term safety. We also observed that mice in the HA@RH-CeO X group showed higher Ce deposition in their liver, spleen, and kidneys compared with the CeO X group (Figure S11F), showing their enhanced degradation and clearance capability.…”
Section: Resultssupporting
confidence: 89%
“…Notably, after 3 days of continuous incubation, Ce predominantly deposited in liver, spleen, and kidney of the mice (Figure S10B). The observations immediately suggested that Ce species released from decomposed micelles could be gradually excreted from the body after completing their anti-inflammatory functions and was also consistent with the excretion mechanisms of transitional metal species in previous reports, thus achieving balanced RA treatment efficacy and long-term safety. We also observed that mice in the HA@RH-CeO X group showed higher Ce deposition in their liver, spleen, and kidneys compared with the CeO X group (Figure S11F), showing their enhanced degradation and clearance capability.…”
Section: Resultssupporting
confidence: 89%
“…[ 81 ] Furthermore, SPT could be used for rheumatoid arthritis (RA) treatment by Fe/BiOCl piezoelectric nanomaterial. [ 82 ]…”
Section: Nanomedicine‐enabled Sonopiezoelectric Therapy (Spt)mentioning
confidence: 99%
“…Furthermore, SPT could be used for rheumatoid arthritis (RA) treatment by Fe/BiOCl piezoelectric nanomaterial. [82] Evidently, the nanomedicine-enabled SPT has vast application potential in several biomedical disciplines. Despite the accumulation of substantial evidence to date, the biological or physical mechanisms underlying them are still poorly understood, and their clinical translation has not yet been achieved.…”
Section: Us-activated Piezoelectric Nanomedicine For Tissue Engineeri...mentioning
confidence: 99%
“…[13] In addition, US irradiation exhibited high tissue penetration (≈10 cm), targeted focus on deep tumors, and non-invasive nature, making it a potential candidate for an external activation source in medicine. [14] Currently, the exploration of therapeutic piezoelectric material is becoming a new research hotspot, while only several ones such as BaTiO 3 , [15] Bi 2 MoO 6 , [16] BiOCl, [17] NaNbO 3 , [18] and ZnO [19] have been reported. The reaction rates of some therapeutic piezoelectric catalysts still needs to be improved because the critical Gibbs free energy threshold obtained from periodic mechanical Scheme 1.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, the exploration of therapeutic piezoelectric material is becoming a new research hotspot, while only several ones such as BaTiO 3 , [ 15 ] Bi 2 MoO 6 , [ 16 ] BiOCl, [ 17 ] NaNbO 3 , [ 18 ] and ZnO [ 19 ] have been reported. The reaction rates of some therapeutic piezoelectric catalysts still needs to be improved because the critical Gibbs free energy threshold obtained from periodic mechanical forces is not high enough to initiate redox reactions.…”
Section: Introductionmentioning
confidence: 99%